ABBOTT LABORATORIES (NYSE:ABT) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders.
On May 3, 2017 Abbott filed a Form 8-K summarizing the matters voted on at its Annual Meeting of Shareholders held on April 28, 2017 (the May 3, 2017 Form 8-K).
In accordance with the Board of Directors recommendation and based on the results of the vote reported under item (4) of the May 3, 2017 Form 8-K, the Board of Directors has determined that Abbott will hold an advisory vote on the compensation of the named executive officers listed in the proxy statement for its Annual Meeting of Shareholders annually.
The information reported under Item 5.07 of the May 3, 2017 Form 8-K is hereby incorporated by reference.
About ABBOTT LABORATORIES (NYSE:ABT) Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture and sale of a line of healthcare products. The Company operates in four business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. The Established Pharmaceutical Products segment includes the international sales of a line of branded generic pharmaceutical products. The Nutrition Products segment includes the sales of a line of adult and pediatric nutritional products. The Diagnostic Products includes the sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products includes the sales of coronary, endovascular, structural heart, vessel closure and other medical device products.